Skip to main content
OpenTrials
Completed

NCT Number: NCT02903758

Frequency and Distribution of Mixed Falciparum-vivax Infections in French Guiana

Malaria is still endemic in the interior of French Guiana. mixed infections by 2 or more different malaria parasites lead to complex and potentially harmfull therapeutic problems. The aim of the study was to look at malaria smears between 2000 and 2008 and determine using PCR the frequency of mixed infections, and their distribution in the terrtory of French Guiana. Overall 10.75% of 400 smears showed mixed infection with P. falciparum and P. vivax. The Maroni river where Duffy negative populations live was largely devoid of vivax infections. These results suggest that mixed infections are frequent in french guiana except on the Maroni river which leads to practical implications for clinicians facing a patient with clinical malaria.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier de Cayenne

Cayenne, French Guiana, 97306, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • malaria diagnosis

Exclusion criteria

  • no malaria

Treatment and study plan

cross sectional

Other

Primary outcomes

  1. malaria

    Time frame: At the time of diagnosis of malaria

    PCR positive for malaria parasites

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Cayenne

Other

Collaborators

  • universite de guyane

Registry information

Acronym: MixMal

Important dates

Study start
2000
Primary completion
2000
Study completion
2008
First posted
Sep 16, 2016
Registry last updated
Sep 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.